In contrast to SCLC, LCNEC of the lung is genetically more heterogeneous, with TP53/RB1 co-inactivation only in a subset of tumors, while those lacking these alterations harbor mutations that are more frequently seen in pulmonary adenocarcinomas43,44. This evidence concerns the gene TP53 and small cell lung carcinoma.